Andrew D. Huber

1.2k total citations
44 papers, 952 citations indexed

About

Andrew D. Huber is a scholar working on Molecular Biology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Andrew D. Huber has authored 44 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Infectious Diseases and 12 papers in Pharmacology. Recurrent topics in Andrew D. Huber's work include Pharmacogenetics and Drug Metabolism (12 papers), HIV/AIDS drug development and treatment (12 papers) and HIV Research and Treatment (11 papers). Andrew D. Huber is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), HIV/AIDS drug development and treatment (12 papers) and HIV Research and Treatment (11 papers). Andrew D. Huber collaborates with scholars based in United States, Japan and United Kingdom. Andrew D. Huber's co-authors include Stefan G. Sarafianos, Taosheng Chen, Karen A. Kirby, Zhengqiang Wang, Jing Tang, Charles J. Alpert, Mary C. Casey, Michael A. Parniak, Jayakanth Kankanala and Daniel J. Wilson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Andrew D. Huber

42 papers receiving 941 citations

Peers

Countries citing papers authored by Andrew D. Huber

Since Specialization

Citations

This map shows the geographic impact of Andrew D. Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Huber more than expected).

Fields of papers citing papers by Andrew D. Huber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Huber. The network helps show where Andrew D. Huber may publish in the future.

Co-authorship network of co-authors of Andrew D. Huber

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Huber. A scholar is included among the top collaborators of Andrew D. Huber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Huber. Andrew D. Huber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PROTAC repurposing uncovers a noncanonical binding surface that mediates chemical degradation of nuclear receptors 2025 ·Nature Communications ·Andrew D. Huber, Wenwei Lin, Kwan‐Young Jung, (unknown), Guangwei Yang, Jing Wu, (unknown), Vishwajeeth Pagala, Wei Wang, Yingxue Fu, Zuo‐Fei Yuan, Stephanie D. Byrum, Ka Yang, (unknown), (unknown), Allister J. Loughran, Jingheng Wang, Shondra M. Pruett‐Miller, Junmin Peng, Taosheng Chen	0
2	Subtle changes in ligand-receptor interactions dramatically alter transcriptional outcomes of pregnane X receptor modulators 2025 ·Structure ·Andrew D. Huber, (unknown), Wenwei Lin, (unknown), Jing Wu, Darcie J. Miller, Taosheng Chen	0
3	Chemical manipulation of an activation/inhibition switch in the nuclear receptor PXR 2024 ·Nature Communications ·(unknown), Andrew D. Huber, Sergio C. Chai, Stanley Nithianantham, Yongtao Li, Jing Wu, (unknown), Darcie J. Miller, J. Seetharaman, Taosheng Chen	13
4	PROTAC-mediated activation, rather than degradation, of a nuclear receptor reveals complex ligand-receptor interaction network 2024 ·Structure ·Andrew D. Huber, Wenwei Lin, (unknown), Darcie J. Miller, Taosheng Chen	8
5	Ligand flexibility and binding pocket malleability cooperate to allow selective PXR activation by analogs of a promiscuous nuclear receptor ligand 2023 ·Structure ·Andrew D. Huber, (unknown), Yongtao Li, Wenwei Lin, Jing Wu, Darcie J. Miller, Taosheng Chen	9
6	A bromodomain-independent mechanism of gene regulation by the BET inhibitor JQ1: direct activation of nuclear receptor PXR 2023 ·Nucleic Acids Research ·Andrew D. Huber, (unknown), Jing Wu, Darcie J. Miller, Wenwei Lin, Lei Yang, (unknown), (unknown), (unknown), J. Seetharaman, Sergio C. Chai, Taosheng Chen	6
7	The F-box-only protein 44 regulates pregnane X receptor protein level by ubiquitination and degradation 2023 ·Acta Pharmaceutica Sinica B ·(unknown), Andrew D. Huber, Jing Wu, Richa Bajpai, Allister J. Loughran, Shondra M. Pruett‐Miller, Taosheng Chen	8
8	Mechanisms of Action of the Host-Targeting Agent Cyclosporin A and Direct-Acting Antiviral Agents against Hepatitis C Virus 2023 ·Viruses ·Dandan Liu, (unknown), (unknown), Andrew D. Huber, Eleftherios Michailidis, Charles M. Rice, Robert Ralston, Philip R. Tedbury, Stefan G. Sarafianos	1
9	Regulation of Nuclear Receptors PXR and CAR by Small Molecules and Signal Crosstalk: Roles in Drug Metabolism and Beyond 2022 ·Drug Metabolism and Disposition ·(unknown), Andrew D. Huber, Taosheng Chen	26
10	Unraveling the Structural Basis of Selective Inhibition of Human Cytochrome P450 3A5 2021 ·Journal of the American Chemical Society ·Jingheng Wang, Cameron D. Buchman, J. Seetharaman, Darcie J. Miller, Andrew D. Huber, Jing Wu, Sergio C. Chai, (unknown), William C. Wright, (unknown), Taosheng Chen	13
11	Clobetasol Propionate Is a Heme-Mediated Selective Inhibitor of Human Cytochrome P450 3A5 2020 ·Journal of Medicinal Chemistry ·William C. Wright, (unknown), Jingheng Wang, Hazel M. Girvan, Lei Yang, Sergio C. Chai, Andrew D. Huber, Jing Wu, Peter Oladimeji, Andrew W. Munro, Taosheng Chen	34
12	CITCO Directly Binds to and Activates Human Pregnane X Receptor 2019 ·Molecular Pharmacology ·Wenwei Lin, (unknown), Jing Wu, Yongtao Li, Sergio C. Chai, Andrew D. Huber, Taosheng Chen	26
13	Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral Cores 2018 ·ACS Infectious Diseases ·Andrew D. Huber, (unknown), Dandan Liu, (unknown), A.T. Gres, Jennifer J. Wolf, Emily Coonrod, Jing Tang, Thomas G. Laughlin, (unknown), Maritza Puray‐Chavez, Juan Ji, Kamalendra Singh, Karen A. Kirby, Zhengqiang Wang, Stefan G. Sarafianos	15
14	5-Aminothiophene-2,4-dicarboxamide analogues as hepatitis B virus capsid assembly effectors 2018 ·European Journal of Medicinal Chemistry ·Jing Tang, Andrew D. Huber, (unknown), (unknown), Jennifer J. Wolf, Jayakanth Kankanala, Jiashu Xie, Stefan G. Sarafianos, Zhengqiang Wang	17
15	6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity 2018 ·European Journal of Medicinal Chemistry ·Lei Wang, Jing Tang, Andrew D. Huber, Mary C. Casey, Karen A. Kirby, Daniel J. Wilson, Jayakanth Kankanala, Jiashu Xie, Michael A. Parniak, Stefan G. Sarafianos, Zhengqiang Wang	27
16	Synthesis, biological evaluation and molecular modeling of 2-Hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymerase 2017 ·European Journal of Medicinal Chemistry ·Jing Tang, Sanjeev Kumar V. Vernekar, (unknown), (unknown), Andrew D. Huber, (unknown), Stefan G. Sarafianos, Michael A. Parniak, Zhengqiang Wang	23
17	Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H 2017 ·European Journal of Medicinal Chemistry ·Jayakanth Kankanala, Karen A. Kirby, Andrew D. Huber, Mary C. Casey, Daniel J. Wilson, Stefan G. Sarafianos, Zhengqiang Wang	37
18	Multiplex single-cell visualization of nucleic acids and protein during HIV infection 2017 ·Nature Communications ·Maritza Puray‐Chavez, Philip R. Tedbury, Andrew D. Huber, (unknown), (unknown), Dandan Liu, (unknown), Jennifer J. Wolf, Alan Engelman, Stefan G. Sarafianos	43
19	Hypersusceptibility mechanism of Tenofovir-resistant HIV to EFdA 2013 ·Retrovirology ·Eleftherios Michailidis, Emily Ryan, Atsuko Hachiya, Karen A. Kirby, Bruno Marchand, Maxwell D. Leslie, Andrew D. Huber, Yee Tsuey Ong, (unknown), Kamalendra Singh, Eiichi Kodama, Hiroaki Mitsuya, Michael A. Parniak, Stefan G. Sarafianos	31
20	New placement prediction and mitigation techniques for local routing congestion 2010 ·International Conference on Computer Aided Design ·(unknown), Charles J. Alpert, Andrew D. Huber, Zhuo Li, Gi-Joon Nam, Shyam Ramji	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact